Mercer Global Advisors’s Evofem Biosciences, Inc. Common Stock EVFM Stock Holding History

Mercer Global Advisors’s Portfolio EVFM Stock Details EVFM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-15,001	Closed	-$17K	–	1946
2022 Q2	$17K	Buy	+15,001	New	+$24.7K	﹤0.01%	1803

Other funds holding EVFM

Clear Street New York $24.6B AUM 56.26% 1-Year Est. Return

AWM

Activest Wealth Management Aventure, Florida $518M AUM 44.34% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

WIM

Westside Investment Management Santa Monica, California $653M AUM 28.36% 1-Year Est. Return

LTI

Laffer Tengler Investments Nashville, Tennessee $782M AUM 33.6% 1-Year Est. Return

Mercer Global Advisors's EVFM Position: Q3 2022 in Review

Mercer Global Advisors sold out of Evofem Biosciences, Inc. Common Stock (EVFM) in Q3 2022, closing a stake of 15,001 shares — an estimated $17K sold.

Mercer Global Advisors first reported a position in EVFM in Q2 2022 and held it in 1 quarter. The position peaked at $17K in Q2 2022. 8 funds tracked by Wall St. Rank hold EVFM as of Q3 2022.

Mercer Global Advisors reported no remaining Evofem Biosciences, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
Mercer Global Advisors sold 15,001 Evofem Biosciences, Inc. Common Stock shares in Q3 2022, an estimated $17K.
Mercer Global Advisors first reported a position in Evofem Biosciences, Inc. Common Stock in Q2 2022 and held it in 1 quarter.
Mercer Global Advisors's Evofem Biosciences, Inc. Common Stock position peaked at $17K in Q2 2022.
8 funds tracked by Wall St. Rank held Evofem Biosciences, Inc. Common Stock as of Q3 2022.

Based on Mercer Global Advisors's 13F filing for Q3 2022, filed 15 Nov 2022.